COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

Abstract Background Patients with alpha-1 antitrypsin deficiency (AATD), commonly categorized as a rare disease, have been affected by the changes in healthcare management brought about by COVID-19. This study’s aim was to identify the changes that have taken place in AATD patient care as a result o...

Full description

Bibliographic Details
Main Authors: Myriam Calle Rubio, José Luis López-Campos, Marc Miravitlles, Francisco Javier Michel de la Rosa, José María Hernández Pérez, Carmen Montero Martínez, José Bruno Montoro Ronsano, Francisco Casas Maldonado, Juan Luis Rodríguez Hermosa, Eva María Tabernero Huguet, José Manuel Martínez Sesmero, Carlos Martínez Rivera, Francisco Javier Callejas González, María Torres Durán
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Health Services Research
Subjects:
COVID-19
Alpha-1-antitrypsin deficiency
Recommendations
Patient management
Healthcare system
Rare disease
Online Access:https://doi.org/10.1186/s12913-023-09094-3

Internet

https://doi.org/10.1186/s12913-023-09094-3

Similar Items